330 Mercy Health Research, 12680 Olive Blvd Suite 200 — St Louis, Missouri

330 Mercy Health Research, 12680 Olive Blvd Suite 200 is a clinical research site located in St Louis, Missouri, United States 63141.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

330 Mercy Health Research, 12680 Olive Blvd Suite 200 has participated in 1 clinical trials.

Therapeutic areas: Influenza.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 330 Mercy Health Research, 12680 Olive Blvd Suite 200?

330 Mercy Health Research, 12680 Olive Blvd Suite 200 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 330 Mercy Health Research, 12680 Olive Blvd Suite 200 conducted?

330 Mercy Health Research, 12680 Olive Blvd Suite 200 has 1 clinical trials on record. Their work covers Influenza.

Is 330 Mercy Health Research, 12680 Olive Blvd Suite 200 accredited by Crixeo Health?

330 Mercy Health Research, 12680 Olive Blvd Suite 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 330 Mercy Health Research, 12680 Olive Blvd Suite 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.